Kalvista

Therapies for hereditary angioedema and diabetic macular edema based on small molecule plasma kallikrein inhibitors

placeCambridge, Massachusetts, United States calendar_todayFounded 2011 groups118 employees language kalvista.com

Registered entities

Social engagement

Social engagement: 15.2K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital450%
Private equity113%
Other / undisclosed338%
Coming soon